Wockhardt · NSE: WOCKPHARMA · BSE: 532300
Q3 FY26 results · Oct–Dec 2025
Wockhardt reported revenue from operations of ₹888.00 crore (up 23.2% from Q3 FY25) and net profit of ₹61.00 crore (up 205.0% from Q3 FY25) for Q3 FY26 (Oct–Dec 2025), on a consolidated basis.
| Item | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 888.00 | 721.00 | +23.2% | 782.00 | +13.6% |
| Other income | 25.00 | 8.00 | +212.5% | 21.00 | +19.0% |
| Total income | 913.00 | 729.00 | +25.2% | 803.00 | +13.7% |
| Profit before tax | 67.00 | 21.00 | +219.0% | 91.00 | −26.4% |
| Net profit for the period | 61.00 | 20.00 | +205.0% | 82.00 | −25.6% |
| Attributable to shareholders of the company | 59.00 | 14.00 | +321.4% | 78.00 | −24.4% |
| EPS, basic (₹) | 3.61 | 0.91 | +296.7% | 4.81 | −24.9% |
| Net margin (%) | 6.9 | 2.8 | 10.5 |
| Item | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 430.00 | 325.00 | +32.3% | 380.00 | +13.2% |
| Other income | 27.00 | 6.00 | +350.0% | 30.00 | −10.0% |
| Total income | 457.00 | 331.00 | +38.1% | 410.00 | +11.5% |
| Profit before tax | 28.00 | (22.00) | Turned profit | 54.00 | −48.1% |
| Net profit for the period | 28.00 | (22.00) | Turned profit | 54.00 | −48.1% |
| EPS, basic (₹) | 1.73 | (1.40) | Turned profit | 3.26 | −46.9% |
| Net margin (%) | 6.5 | -6.8 | 14.2 |
Consolidated
- Filed with BSE
- 10 Feb 2026, 15:08 IST
- Board meeting
- 10 Feb 2026
- Period
- 01 Oct 2025 to 31 Dec 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 10 Feb 2026, 15:08 IST
- Board meeting
- 10 Feb 2026
- Period
- 01 Oct 2025 to 31 Dec 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE